FULC
Fulcrum Therapeutics Inc
3.80$
-0.8%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +14.8% | -100.0% | – | -100.0% | – | – | – | – | – | – | – | – | |
| – | -97.2% | -5.7% | +3,503.5% | -15.2% | -97.5% | +3,532.5% | -97.8% | +4,665.3% | -102.1% | – | -36.1% | – | |
| – | – | -232.0% | – | -123.3% | – | – | – | – | – | -212.7% | – | – | |
| – | +4.2% | +1.6% | -10.5% | -15.2% | -22.5% | +18.2% | -3.1% | +10.1% | +7.8% | -8.6% | -11.6% | – | |
| – | +5.8% | +2.0% | -0.8% | -18.4% | -5.2% | -13.3% | +2.0% | +6.9% | -0.3% | +11.3% | -7.9% | – | |
| – | +184.7% | +3.5% | -65.1% | +2.3% | +81.7% | -63.3% | +178.8% | -61.3% | +204.1% | -5.0% | -9.9% | – | |
| – | – | – | – | -147.9% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -139.2% | – | – | – | – | – | – | – | – | |
| – | +673.0% | -86.2% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -139.2% | – | – | – | – | – | – | – | – | |
| – | – | – | – | -140.7% | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.